Sharon Henderson

Octane names veteran Janelle Brunette its first female CEO, a move positioning the SoCal powerhouse for deeper impact and its next phase of strategic growth.

By hiring top drug and deal makers, Bexorg signals its AI-powered human brain platform is ready to move from a bold experiment to a commercial powerhouse.

WTWH Media's rebrand to Arrowfly isn't just a name change. It's a strategic consolidation fueled by private equity, aiming to redefine B2B engagement.

A Swiss biotech's oral drug just showed it can cross into the human brain and alter its activity, a key de-risking step in a high-stakes pivot.

By achieving top B-BBEE status, John Crane didn't just check a box; it executed a strategic move to reshape its competitive landscape in South Africa.

America First's acquisition of Meadows Bank is hailed as a win-win. But as a local bank’s legacy is absorbed, what does this trend mean for customers and accountability?

SparDanmark Invest's trading was briefly suspended again. This recurring technical failure at administrator Nykredit raises critical questions about financial system resilience.

A C$2M financing for Resouro's Tiros project isn't just about capital; it's a calculated move to de-risk a critical minerals asset in Brazil.

With its stock lagging, Vermilion Energy renews a major share buyback, a defiant signal of undervaluation. Is this a savvy capital play or a bet against market headwinds?

Harvest Sherwood is dead, but its legal claims are worth a fortune. Atlas Grove's high-stakes plan isn't revival, but a billion-dollar war on an entire industry.

Facing a 400,000-person talent gap, the insurance industry sees a pivotal move as The Institutes provides a strategic lifeline to Young Risk Professionals.

Chevron's new licensing deal with ZL Chemicals is more than a press release. It's a strategic masterstroke in monetizing dormant IP and reshaping the EOR market.

As AI fights financial crime, one firm's new certification raises a critical question: Can a global standard finally ensure our digital guardians are accountable?

Beyond record gold output, K92 Mining’s Q2 results reveal a strategic blueprint for growth, engineering prowess, and navigating geopolitical complexity.

With its Q1 results imminent, Champion Iron isn't just reporting numbers. It's testing a high-stakes strategy to supply the world's green steel future.

As First Industrial Realty Trust preps its Q2 report, its performance is more than numbers—it's a barometer for supply chain resilience and market discipline.

New long-term data shows a 60-day nerve stimulation treatment helps 8 in 10 patients avoid surgery, challenging the entire strategy for chronic pain.

A new partnership between Cynet and Pax8 isn't just another deal. It is a calculated move to arm MSPs against fragmented defenses and complex cyber threats.

AstraZeneca's new deal with genomics firm Helix isn't just a partnership; it's a bet on a future where drug discovery is driven by massive data vaults.

As foldable phones and tablets flood the market, their returns create a costly logistical nightmare. A new robotic system reveals a deeper strategy to master the circular economy.